LUMASIRAN SODIUM | N214103 | ALNYLAM PHARMACEUTICALS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8106022 | Dec 12, 2029 | — | Yes | Yes | — | |
| 8828956 | Dec 4, 2028 | — | Yes | Yes | — | |
| 9828606 | Dec 26, 2034 | — | Yes | Yes | — | — |
| 10131907 | Aug 24, 2028 | — | Yes | Yes | — | |
| 10435692 | Dec 26, 2034 | — | — | — | — | |
| 10465195 | Dec 26, 2034 | — | Yes | Yes | — | |
| 10478500 | Oct 9, 2035 | — | Yes | Yes | — | |
| 10487330 | Dec 26, 2034 | — | Yes | Yes | — | |
| 10612024 | Aug 14, 2035 | — | Yes | Yes | — | |
| 10612027 | Aug 14, 2035 | — | Yes | Yes | — | |
| 11060093 | Dec 26, 2034 | — | Yes | Yes | — | |
| 11261447 | Nov 20, 2038 | — | Yes | Yes | — | |
| 11401517 | Aug 14, 2035 | — | Yes | Yes | — | |
| 11446380 | Oct 9, 2035 | — | Yes | Yes | — | — |
| Code | Date | Status |
|---|---|---|
| ODE-339 | Nov 23, 2027 | Active |
| ODE-415 | Oct 6, 2029 | Active |